Wearlinq, maker of a wireless clinical-grade wearable 6-lead EKG, has secured a $14 million Series A investment, and $5 million in venture debt funding.
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...
New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...
According to the Centers for Disease Control (CDC), approximately 610,000 people die of heart disease in the U.S. every year — that’s one in every four deaths 1. Cardiac health is one of the most ...
SAN FRANCISCO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous ...
iRhythm's LTCM showed superior performance in arrhythmia diagnosis, fewer retests, and lower cardiovascular events compared to other ACMs. The study used inverse probability of treatment weighting to ...
Whether you’re practising meditation, enjoying a leisurely walk, or simply getting the right amount of rest, taking care of your heart is crucial for living a long, healthy life. With heart disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback